Showing 151-160 of 2569 results for "".
Surviving Stroke: 2 Surgeons Experience with Recovery
https://practicalneurology.com/diseases-diagnoses/stroke/surviving-stroke-2-surgeons-experience-with-recovery/30087/Siva Murugappan, MD, General Surgeon, Chatham-Kent Health Alliance, Ontario, Canada, shares his own experiences as a patient recovering from an ischemic stroke. He is joined by his wife and caregiver, Dr. Prema Samy, Otolaryngologist, Chatham-Kent Health Alliance, Ontario, Canada, as they both discuCould a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea?Insights From the SynAIRgy Trial
https://practicalneurology.com/diseases-diagnoses/sleep/could-a-novel-oral-therapy-change-how-clinicians-treat-obstructive-sleep-apnea-insights-from-the-synairgy-trial/68963/In this episode, Patrick J. Strollo Jr, MD, FACP, FCCP, FAASM, of the University of Pittsburgh Department of Medicine, Pittsburgh, PA, discusses the data from the phase 3 SynAIRgy clinical trial for AD109, an investigational once-nightly oral treatment targeting neuromuscular dysfunction in obstructNMOSD Part 1 - Overview and important considerations for diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-1-overview-and-important-considerations-for-diagnosis/30086/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podMaturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice
https://practicalneurology.com/diseases-diagnoses/headache-pain/maturing-with-migraine-practical-guidelines-for-transitioning-adolescent-migraine-and-headache-patients-into-adult-practice/48903/Hope O’Brien, MD, MBA, FAHS, FAAN, Founder and CEO of the Headache Center of Hope, Cincinnati, OH, discusses challenges and considerations for adult headache neurologists who are onboarding adolescent patients as they transition from pediatric practice. Dr. O’Brien highlights a framework with strateNavigating Treatment Decisions for Individuals with Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/navigating-treatment-decisions-for-individuals-with-spinal-muscular-atrophy/39222/Spinal muscular atrophy (SMA) care has shifted dramatically with the introduction of disease-modifying therapies, but how do clinicians weigh treatment options across different patient populations? In this episode of NeuroFrontiers, Charles Turck, PharmD, BCPS, BCCP, speaks with John Brandsema, MD aThe Consequences of Delays in the Diagnosis of Generalized Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-consequences-of-delays-in-the-diagnosis-of-generalized-myasthenia-gravis/39223/Delayed diagnosis of generalized myasthenia gravis is a common challenge, often leading to misdiagnosis, increased disease severity, and reduced quality of life. In this episode of NeuroFrontiers, John A. Morren, MD, FAAN, FAANEM discusses why diagnostic delays occur, how they impact patient outcomeUpdates from the American Headache Society: Diagnostic Criteria, Preventive CGRP Therapy, and Treatment Guidance
https://practicalneurology.com/diseases-diagnoses/headache-pain/updates-from-the-american-headache-society-diagnostic-criteria-preventive-cgrp-therapy-and-treatment-guidance/37873/Jessica Ailani, MD, FAHS, FAAN, FANA, Clinical Professor of Neurology at MedStar’s Georgetown University Hospital and Director of the MedStar Georgetown Headache Center, joins Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, to review essential American Headache Society updates for migrExpert Perspective on Ocrelizumab and More
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/expert-perspective-on-ocrelizumab-and-more/30368/Neurology in the Media
https://practicalneurology.com/columns/practice-management/neurology-in-the-media/30322/Where #Neurology and Culture IntersectGeneralized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/generalized-myasthenia-gravis-inside-the-mint-trial-and-cd19-b-cell-therapy-advances/57164/Richard J. Nowak, MD, MS, Associate Professor of Neurology, Yale School of Medicine, Yale University, New Haven, CT and global principal investigator of the Myasthenia Gravis Inebilizumab Trial (MINT), discusses the phase 3 results, highlighting the safety and efficacy of CD19-targeted B-cell therap